Abbott reiterated as a top large-cap pick at JPMorgan

JPMorgan analyst Robbie Marcus reiterates Abbott Laboratories as a top large-cap pick following a headquarter visit. With 2019 Street earnings estimates of $3.20 reflecting “just” 11% growth, the analyst sees “multiple pathways to upside” on both the top and bottom lines next year. He come away from the visit “even more bullish on the multi-year growth story for Alinity.” Marcus keeps an Overweight rating on Abbott with an $81 price target.
https://thefly.com/landingPageNews.php?id=2828391